Protein-protein interactions (PPIs) underlie most, if not all, cellular functions. The comprehensive mapping of these complex networks of stable and transient associations thus remains a key goal, both for systems biology-based initiatives (where it can be combined with other 'omics' data to gain a better understanding of functional pathways and networks) and for focused biological studies. Despite the significant challenges of such an undertaking, major strides have been made over the past few years. They include improvements in the computation prediction of PPIs and the literature curation of low-throughput studies of specific protein complexes, but also an increase in the deposition of high-quality data from non-biased high-throughput experimental PPI mapping strategies into publicly available databases.
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A range of complementary approaches are currently being used to identify protein-protein interactions (PPIs) in a large-scale, highthroughput manner (Figure 1 ). These include affinity purificationmass spectrometry (AP-MS), cross-linking MS (XL-MS) analysis, MS-based protein correlation profiling (PCP), and yeast two-hybrid (Y2H) screens. Proximity labeling techniques, based on the identification (by AP-MS) of near neighbor proteins by spatially restricted enzymes, can also be used to map protein networks and probe complex structures, although they have yet to be applied at a whole proteome level. In this review, we discuss recent applications of these diverse methods to large-scale protein interactome mapping and the public availability of the resulting datasets for both high-throughput bioinformatic analysis of protein interaction networks and singleprotein information for more focused studies.
Affinity purification-mass spectrometry-based largescale protein-protein interaction mapping initiatives
Currently, the most popular strategy for both high-and lowthroughput interactome mapping is AP-MS, in which an endogenous or tagged bait protein is depleted from cell lysates by using an affinity resin and associated proteins identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS) ( Figure 1a) . Two recent large-scale studies of human PPIs used AP-MS approaches to identify more than 20,000 interactions, respectively ( Table 1) . To assemble what they call the BioPlex (biophysical interactions of ORFeome-derived complexes), Huttlin and colleagues C-terminally FLAG-HA tagged about 600 human open reading frames (ORFs) and transiently overexpressed them in HEK293T cells, identifying co-precipitating proteins by AP-MS Clone validation, quality control, inclusion of positive and negative controls, and development of a quantitation algorithm (CompPASSPlus) based on abundance, detection frequency, and reproducibility were employed to increase confidence in the resulting dataset, which was deposited into the BioGRID PPI database last year. The authors consider this to be phase 1 of their long-term effort to map interactomes for the entire human ORFeome collection and are continuing to post updates that can be freely browsed or downloaded from their website.
The approach used by Hein and colleagues 2 involved screening a library of 1,125 HeLa cell lines with stably incorporated N-and C-terminally tagged mouse and human bacterial artificial chromosome (BAC) transgenes under near endogenous control 3 by AP-MS, as demonstrated previously in focused studies analyzing chromosome segregation 4 and the function of motor proteins
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. In addition to identifying more than 28,000 interactions in their largescale screen, the authors estimated interaction stoichiometries (based on absolute quantitation of protein abundances in complexes and compared for both N-and C-terminally tagged and mouse and human bait proteins) and measured the relative cellular abundances of interaction partners. An interesting finding was the predominance of weak (i.e., sub-stoichiometric) interactions in the global interactome, which may suggest that stable complexes rely on weak links to connect to each other and to transient/dynamic regulators. The interaction datasets were submitted to both the IntAct database and the IMEx consortium.
Importantly, both studies demonstrated significant overlap with the CORUM (Comprehensive Resource of Mammalian protein complexes) database, a manually curated repository of more than 2,800 mammalian protein complexes 6 . CORUM is currently considered the "gold standard" PPI database because it is based solely on high-confidence, experimentally verified interactions and does not accept deposition of large-scale datasets (Table 2) . Proteome coverage was also high for both studies, as assessed by comparison with datasets generated and shared in recent largescale whole proteome mapping initiatives ( Although the standard caveats of AP-MS strategies still apply, namely the potential for overexpression or tag-induced artefacts and the predominance of false positives such as non-specific background proteins 12-14 and the recently described cryptic protein binding to cloning regions or "scars" where affinity tags are linked to the gene of interest 15 , these large-scale studies benefit tremendously from the comparison of multiple experiments. Negative controls are largely bait-independent, and thus common contaminants are highlighted by their appearance in numerous unrelated datasets. Moving forward, the limitations of AP-MS can be further minimized by a variety of strategies, including direct affinity tagging of endogenous proteins using the powerful CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/Cas9) gene editing tool 16, 17 , more rigorous assessment of the quality and specificity of antibodies used to capture endogenous proteins for , and improvements in significance analysis software 19, 20 . Two particular proximity labeling techniques, BioID and APEX, have been employed recently for the analysis of multiprotein complexes and for identification of the protein components of specific cellular compartments (Figure 1b) . BioID involves expression of a protein of interest fused to a prokaryotic biotin ligase and the subsequent biotinylation of amine groups on neighboring proteins when excess biotin is added to the cells. Whereas the wild-type BirA biotin ligase from Escherichia coli is capable of transferring biotin only to a substrate bearing a specific recognition sequence, the generation of a promiscuous BirA (Arg118Gly mutant) permits the biotinylation of any protein found within a 10-nm labeling radius 21, 22 . As with AP-MS, identification of a protein-protein association using BioID does not imply a direct physical interaction.
BioID has enabled the identification of proteins involved in important functional complexes that were previously difficult to characterize because of the limitations of AP-MS. For example, the identification of ubiquitin ligase substrates by AP-MS is challenging and this is due in part to the weak and transient interactions observed between the ligase and its substrates. A BioID approach, however, facilitated identification of novel substrates 23 . This type of approach has also been used to identify novel c-MYC 24 and HIV-1 Gag 25 interacting partners, highlight force-dependent molecular interactions at cell-cell adhesions 26 , identify proteins localized to cell junction complexes 27,28 and the centrosome-cilium interface 29 , and probe the structure of the centrosome 30,31 and the nuclear pore complex 22 .
APEX is a monomeric peroxidase reporter derived from pea 32 or soybean 33 ascorbate peroxidase that catalyzes the oxidation of biotin-phenol to biotin-phenoxyl in the presence of H 2 O 2 , resulting in the biotinylation of proteins in the neighboring region. Whereas BirA-catalyzed biotinylation is limited to Lys residues, biotinphenoxyl radicals can covalently react with electron-rich amino acids such as Tyr, Trp, His, and Cys. They are also short-lived (<5 ms) and membrane-impermeable and have a small labeling radius (<20 nm). APEX can also catalyze diaminobenzidine precipitation to generate contrast after OsO 4 fixation, which allows confirmation of localization at nanometer resolution by electron microscopy 32 . A second-generation APEX2 (Ala134Pro mutant) with improved efficiency was shown to function even better as both a promiscuous labeling enzyme and an EM tag 34 . Similar to BioID, once proximity labeling has been achieved, biotinylated proteins can be identified via stringent streptavidin purification and MS analysis. An advantage of APEX over BioID is higher temporal resolution, as labeling is achieved on a minute rather than an hour scale.
The APEX reporter has been used to map the proteome of the human mitochondrial intermembrane space and membrane-enclosed mitochondrial matrix 33, 35 , the Drosophila muscle mitochondrial matrix proteome 36 , and the proteome of the cilium 37 . Although the applicability of APEX to interactome mapping out with membrane-bound organelles has not yet been demonstrated, further optimization of the enzyme and substrate could extend its utility.
Large-scale protein-protein interaction mapping initiatives based on alternative approaches
High-quality large-scale interactome datasets have also been assembled using strategies such as XL-MS, which provides additional information about the topographical structure of protein complexes ( Figure 1c and Table 1 ). In the case of XL-MS, progress was initially slowed by the complexity of data acquisition and analysis, in particular the two overlapping series of fragment ions from each peptide that appear in the MS/MS spectrum. Although major advances have been made 38, 39 , including the development of MS-cleavable cross-linkers that fragment efficiently in the MS/MS mode to yield two major fragment ions corresponding to the component peptides (which can be subsequently identified by MS 3 ), sensitivity can be further improved in the future by the addition of pre-fractionation steps, the use of affinity-tagged cross-linking agents or complementary chemistry (i.e., agents that cross-link amino acids other than lysine 40 ), digestion with complementary proteases, and the development of dedicated software for the analysis of complex XL-MS datasets.
Similarly, PCP-MS studies (Figure 1d ) also continue to increase in coverage and specificity, comparing favorably to reference interactome datasets [41] [42] [43] . This approach avoids affinity purification steps and instead separates and maps protein complexes using a variety of approaches that include density gradients and size-exclusion, ion-exclusion, and hydrophobicity interaction chromatography. Given the range of separation options available, PCP-MS also offers significant scope for advancement in the future.
Large-scale binary protein-protein interaction mapping
Although XL-MS does identify direct protein interactions, the other approaches discussed above (AP-MS, proximity labeling, and PCP-MS) can confirm only that proteins exist in the same multiprotein complex. A complementary technique that has been used for more than 20 years to detect direct PPI is the Y2H assay. In this approach, the bait and prey proteins are tagged to the DNA binding and transcriptional activation domains of a split transcription factor, and direct binding drives its reconstitution and subsequent activation of a reporter gene (Figure 1e) . Although limited by technical and biological challenges that include the need to construct large libraries and the high false-negative and -positive rates that arise from the absence of certain post-translational modifications in yeast that govern protein-protein associations in mammalian cells and forced interactions that do not occur in mammalian cells under physiological conditions, the Y2H screen remains a powerful approach for detecting or confirming (or both) binary interactions.
Using the extensive human ORF collection as bait/prey in an ongoing series of large-scale Y2H screens, researchers at the DanaFarber Cancer Institute in Boston are addressing the question of which PPIs in the human interactome are direct 44, 45 . With the longterm goal of mapping the full range of human binary PPIs, their most recent update added about 14,000 new binary interactions, bringing the current total to about 17,000. The full dataset, and future updates, can be browsed using their dedicated web interface (Table 1) .
Conclusions
With a daunting grand plan for these PPI network maps to comprehensively characterize individual protein functions and global proteome organization, it is not surprising that significant challenges remain. As noted above, the stringency and efficiency of protein extraction and depletion remain an issue with AP-MS studies, and traditional mapping strategies still favor the most abundant/robust interactors. It is hoped that, as complementary approaches such as proximity labeling, XL-MS, and PCP-MS increase in sensitivity and specificity, they will provide extended coverage of the interactome. Importantly, as more high-quality large-scale datasets are collected and shared via online interaction databases like MIntAct 46 and BioGRID 47 (Table 2 ), consistencies and patterns will emerge.
Additional technical challenges, posed by their hydrophobic nature, have particularly hampered the identification of PPIs among membrane proteins (and between membrane proteins and soluble proteins such as cytosolic signaling factors). However, the success of recent large-scale initiatives such as the mapping of more than 12,000 binary interactions between Arabidopsis membrane/signaling proteins using the mating-based split ubiquitin system (mbSUS) in yeast 48 and the TAP (tandem affinity purification)-MS based screening of 1,590 putative budding yeast membrane proteins using three different mild, non-denaturing detergent purification strategies in parallel 49 (1,726 PPIs and 501 putative heteromeric complexes identified) demonstrates that these challenges are also surmountable.
Other challenges include the necessity to define PPIs over a wider range of biological contexts, given that some are cell cycle-or developmental stage-specific, for example, or occur only under particular physiological conditions or in response to specific posttranslational modifications. An ambitious future goal is a comprehensive and quantitative high-throughput approach that combines gene-editing with live super-resolution imaging and interactome mapping to define the dynamic localization, composition, and topography of functional multiprotein complexes. and are edited as a F1000 Faculty Reviews F1000 Faculty service to readers. In order to make these reviews as comprehensive and accessible as possible, the referees provide input before publication and only the final, revised version is published. The referees who approved the final version are listed with their names and affiliations but without their reports on earlier versions (any comments will already have been addressed in the published version).
